REFZIL
Brand:
REFZIL
Manufacturer:
RANBAXY
Manufacturer Details
RANBAXY
Compositions:
Cefpirome 0.5mg/1g injection,
|
Strength
|
Rate
|
Packing Style
|
|
0.5mg
|
311.25
|
1 injection
|
|
1g
|
450.00
|
1 injection
|
List of Related Indications:
List Of Drugs:
- Cefpirome sulphate @- Cephalosporin- (FDC-List) (Sep 1997)
Indication Type Description:
Drug Interaction:
Aminoglycosides, loop diuretics, ( monitor renal function )
Indication:
U.S FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
31. Cefpirome (as sulphate) 24-01-08
500/1000mg/2000mg
+ Sulbactam (as sodium)
250mg/500mg/1000mg powder for injection
For the treatment of infection caused by sensitive
organisms viz. lower RTI, complicated UTI,
Septicemia, bacteremia
Lower respiratory tract infection
Skin and soft tissue infection
Urinary tract infection
Bactericemia
Septicemia
Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
1.Cefpirome Anti-infective September 1997
2.Cefpirome sulphate 24-01-2008
500mg/100mg/2000mg + Sulbactum
(as sodium) 250mg/500mg /1000mg
powder for Injection
For the treatment of Infection caused by sensitive organisms viz.
Lower RTI , Complicated UTI, Septicemia,Bacteremia
Adverse Reaction:
Nausea, vomting, diarrhoea, raised liver enzymes and creatinine.
Blood dyscrasias at inj site reactions.
Taste disturbances,
Hypersensitivity reactions including anaphylaxis
Rarely superinfections, intestinal nephritis, renal failure,
pseudomembtaneous colitis
Contra-Indications:
Pregnancy and lactation
Dosages/ Overdosage Etc:
Lower respiratory tract infection
Skin and soft tissue infection
Urinary tract infection
Bactericemia
Septicemia
1-2g every 12 hours by i.v. bolus over 3-5 minutes by i.v. infusion over 20-30 minutes
Not recommended for children
Patient Information:
Pregnancy and lactation - observe caution
